Insider Transactions in Q1 2024 at Humana Inc (HUM)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2024
|
William Kevin Fleming Chief Corporate Aff. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-10.61%
|
$448,716
$366.11 P/Share
|
|
Feb 22
2024
|
William Kevin Fleming Chief Corporate Aff. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,566
+23.59%
|
-
|
|
Feb 22
2024
|
Samir Deshpande Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,302
-9.51%
|
$476,532
$366.11 P/Share
|
|
Feb 22
2024
|
Samir Deshpande Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,770
+21.58%
|
-
|
|
Feb 22
2024
|
Bruce D Broussard Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,473
-8.75%
|
$3,101,118
$366.11 P/Share
|
|
Feb 22
2024
|
Bruce D Broussard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,572
+18.91%
|
-
|
|
Feb 22
2024
|
Vishal Agrawal Chief Strat & Corp Dev Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
959
-8.1%
|
$350,994
$366.11 P/Share
|
|
Feb 22
2024
|
Vishal Agrawal Chief Strat & Corp Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,010
+20.26%
|
-
|
|
Feb 22
2024
|
Timothy S. Huval Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,284
-14.8%
|
$469,944
$366.11 P/Share
|
|
Feb 22
2024
|
Timothy S. Huval Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,712
+29.97%
|
-
|
|
Feb 22
2024
|
Joseph C Ventura Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,153
-14.09%
|
$421,998
$366.11 P/Share
|
|
Feb 22
2024
|
Joseph C Ventura Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,411
+29.43%
|
-
|
|
Feb 22
2024
|
Susan M Diamond Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,125
-15.13%
|
$411,750
$366.11 P/Share
|
|
Feb 22
2024
|
Susan M Diamond Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+31.1%
|
-
|
|
Feb 22
2024
|
George Renaudin Ii President, Medicare & Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-10.49%
|
$101,748
$366.11 P/Share
|
|
Feb 22
2024
|
George Renaudin Ii President, Medicare & Medicaid |
BUY
Exercise of conversion of derivative security
|
Direct |
1,104
+29.4%
|
-
|
|
Feb 21
2024
|
James A. Rechtin President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
4,085
+50.0%
|
-
|
|
Feb 21
2024
|
John Paul W. Felter SVP, Chief Accting Off & Cont. |
BUY
Grant, award, or other acquisition
|
Direct |
490
+40.73%
|
-
|
|
Feb 21
2024
|
William Kevin Fleming Chief Corporate Aff. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+10.64%
|
-
|
|
Feb 21
2024
|
Samir Deshpande Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,464
+9.55%
|
-
|
|
Feb 21
2024
|
Bruce D Broussard Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,786
+16.52%
|
-
|
|
Feb 21
2024
|
Vishal Agrawal Chief Strat & Corp Dev Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,362
+10.01%
|
-
|
|
Feb 21
2024
|
Timothy S. Huval Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,357
+27.06%
|
-
|
|
Feb 21
2024
|
Joseph C Ventura Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,425
+27.87%
|
-
|
|
Feb 21
2024
|
David Dintenfass President, Enterprise Growth |
BUY
Grant, award, or other acquisition
|
Direct |
13,310
+50.0%
|
-
|
|
Feb 21
2024
|
Susan M Diamond Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,480
+40.52%
|
-
|
|
Feb 21
2024
|
George Renaudin Ii President, Medicare & Medicaid |
BUY
Grant, award, or other acquisition
|
Direct |
7,250
+42.97%
|
-
|
|
Feb 21
2024
|
Sanjay K Shetty President, CenterWell |
BUY
Grant, award, or other acquisition
|
Direct |
7,148
+49.42%
|
-
|
|
Feb 20
2024
|
Jorge S. Mesquita Director |
BUY
Open market or private purchase
|
Indirect |
545
+17.45%
|
$200,015
$367.09 P/Share
|
|
Jan 02
2024
|
Jorge S. Mesquita Director |
BUY
Grant, award, or other acquisition
|
Indirect |
430
+17.46%
|
-
|
|
Jan 02
2024
|
John W Garratt Director |
BUY
Grant, award, or other acquisition
|
Direct |
430
+20.33%
|
-
|